Medicare Enrolled

Dr. Roger Yau, M.D.

Urology Physician · Matthews, NC
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1450 MATTHEWS TOWNSHIP PKWY STE 350, Matthews, NC 28105
7048418877
In practice since 2013 (13 years)
NPI: 1780021600 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Yau from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Yau? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Yau

Dr. Roger Yau is an urology physician in Matthews, NC, with 13 years of NPI registration. Based on federal Medicare data, Dr. Yau performed 1,863 Medicare services across 1,511 unique beneficiaries.

Between the years covered by Open Payments, Dr. Yau received a total of $12,414 from 56 pharmaceutical and/or device companies across 355 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Yau is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 13 years in practice ▲ Top 40% volume in NC $12,414 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,863
Medicare services
Top 40% in NC for urology physician
1,511
Unique beneficiaries
$63
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~143 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Manual urinalysis with microscopic examination
A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities.
569 $4 $17
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
464 $87 $158
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
256 $63 $110
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
133 $172 $585
Leuprolide acetate (for depot suspension), 7.5 mg 93 $135 $786
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
81 $7 $45
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
72 $112 $263
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
40 $69 $185
Transrectal ultrasound of the pelvis
An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures.
38 $105 $295
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
27 $133 $231
Subcutaneous or intramuscular chemotherapy injection
This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle.
25 $24 $87
Prostate gland biopsy
A procedure to remove small samples of tissue from the prostate gland for laboratory examination.
22 $165 $626
Injection, garamycin, gentamicin, up to 80 mg 22 $2 $7
Imaging of urinary tract with contrast
An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures.
21 $19 $264
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$12,414
Total received (2018-2024)
Avg $1,773/year across 7 years
Top 12% in NC for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
56
Companies
355
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,960 (96.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$454 (3.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,121
2023
$1,608
2022
$1,412
2021
$1,277
2020
$946
2019
$5,020
2018
$30

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
UROGEN PHARMA, INC.
$293
Sumitomo Pharma America, Inc.
$219
Dendreon Pharmaceuticals LLC
$213
ConvaTec Inc.
$186
Endo USA, Inc.
$183
Myriad Genetic Laboratories, Inc.
$121
Boston Scientific Corporation
$121
Olympus America Inc.
$102
COLOPLAST CORP
$86
Ferring Pharmaceuticals Inc.
$69
PFIZER INC.
$62
Laborie Medical Technologies Corp.
$60
C. R. Bard, Inc. & Subsidiaries
$53
Axonics, Inc.
$51
Teleflex LLC
$45
Merck Sharp & Dohme LLC
$43
Ambu Inc.
$37
ABBVIE INC.
$35
Endo Pharmaceuticals Inc.
$28
Smith+Nephew, Inc.
$25
Astellas Pharma US Inc
$23
Medtronic, Inc.
$22
Janssen Biotech, Inc.
$22
PROGENICS PHARMACEUTICALS, INC.
$21
Top 3 companies account for 34.2% of 2024 payments
All-time payments by company (2018-2024) ›
Intuitive Surgical, Inc.
$4,126
Astellas Pharma US Inc
$940
Sumitomo Pharma America, Inc.
$636
Endo Pharmaceuticals Inc.
$548
Antares Pharma, Inc.
$488
UROGEN PHARMA, INC.
$480
PFIZER INC.
$350
Boston Scientific Corporation
$345
UROVANT SCIENCES INC
$334
Coloplast Corp
$291
Dendreon Pharmaceuticals LLC
$256
Axonics, Inc.
$233
PROCEPT BioRobotics Corporation
$223
UroGen Pharma, Inc.
$209
Medtronic, Inc.
$193
ConvaTec Inc.
$186
Endo USA, Inc.
$183
AbbVie Inc.
$175
ABBVIE INC.
$157
Richard Wolf Medical Instruments Corp.
$146
NeoTract Inc.
$137
COLOPLAST CORP
$123
Myriad Genetic Laboratories, Inc.
$121
Olympus America Inc.
$119
C. R. Bard, Inc. & Subsidiaries
$116
BOSTON SCIENTIFIC CORPORATION
$115
Laborie Medical Technologies Corp.
$109
Janssen Biotech, Inc.
$76
Teleflex LLC
$75
Ferring Pharmaceuticals Inc.
$69
Smith+Nephew, Inc.
$69
Rochester Medical Corporation
$65
Merck Sharp & Dohme LLC
$63
CONMED Corporation
$61
Merck Sharp & Dohme Corporation
$53
Supernus Pharmaceuticals, Inc.
$53
Ambu Inc.
$50
Allergan, Inc.
$43
ACCORD HEALTHCARE, INC.
$42
Zyla Life Sciences, Inc.
$42
Hollister Incorporated
$37
Tolmar, Inc.
$27
Blue Earth Diagnostics Limited
$24
Zyla Life Sciences
$24
Progenics Pharmaceuticals, Inc.
$21
PROGENICS PHARMACEUTICALS, INC.
$21
Clarus Therapeutics Inc.
$20
Baudax Bio Inc.
$19
AbbVie, Inc.
$18
ABC Home Medical Supply, Inc.
$17
TOLMAR Pharmaceuticals, Inc.
$17
Travere Therapeutics, Inc.
$16
Agiliti Health, Inc.
$14
AXOGEN
$13
Acerus Pharmaceuticals Corporation
$13
DENTSPLY IH Inc.
$11
Top 3 companies account for 45.9% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ADSTILADRIN · ADVANCE · AIRSEAL · AMS · AMS 700 · AMS 800 Artificial Urinary Sphincter · ANJESO · AVANCE NERVE GRAFT · AVEED · AquaBeam Robotic System · Axonics · Axumin · BOTOX · Bard Urinary Drainage Bag · CAMCEVI · CONTINENCE CARE · CURE CATHETER · Da Vinci Surgical System · EDEX · ELIGARD · ERLEADA · GEMTESA · GENERAL ERECTILE DYSFUNCTION · GENERAL KIDNEY STONE DISEASE · General - Erectile Dysfunction · INTERSTIM · Infyna Chic · JATENZO · JELMYTO · KEYTRUDA · LITHOVUE · LUPRON DEPOT · LithoVue · LoFric · Luja Coude · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · ORGOVYX · OTREXUP · Otrexup · PROLARIS · PROVENGE · PYLARIFY · Porges Coloplast · REZUM · Restorelle · SPEEDICATH · SPRIX · STRAVIX · STRAVIX PL · SpeediCath · TITAN · TOVIAZ · TRIA · Titan · UROLIFT · Urgent PC Neuromodulation System · UroLift · UroLift System · VaPro Plus Pocket · XIAFLEX · XTANDI · XYOSTED · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an urology physician in Matthews?
Compare urology physicians in the Matthews area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
75
Per 100K population
6.6
County median income
$83,765
Nearest hospital
NOVANT HEALTH BALLANTYNE MEDICAL CENTER
7.8 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Yau is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 12% of NC peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Yau experienced with manual urinalysis with microscopic examination?
Based on Medicare claims data, Dr. Yau performed 569 manual urinalysis with microscopic examination services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Yau receive payments from pharmaceutical companies?
Yes. Dr. Yau received a total of $12,414 from 56 companies across 355 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Yau's costs compare to other urology physicians in Matthews?
Dr. Yau's average Medicare payment per service is $63. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Yau) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →